In vitro studies on LCSC6 revealed widespread inhibition of the mTOR pathway, in parallel with a massive accumulation of bioactive dihydroceramide lipids, indicating that NanoFEN was able to activate the multifactorial program in cancer cells. This evidence concerns the gene MTOR and cancer.